Variant report
Variant | nsv590781 |
---|---|
Chromosome Location | chr3:82707769-82766788 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7622157 | chr3:82720624-82720625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544012380 | chr3:82720635-82720636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564007054 | chr3:82720644-82720645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187553965 | chr3:82720657-82720658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532847535 | chr3:82720670-82720671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192767180 | chr3:82720678-82720679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552651947 | chr3:82720682-82720683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565888581 | chr3:82720762-82720763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2035185 | chr3:82720792-82720793 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs78820568 | chr3:82720809-82720810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568519181 | chr3:82720946-82720947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7610983 | chr3:82720953-82720954 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs556727292 | chr3:82720975-82720976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559954018 | chr3:82720980-82720981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140996520 | chr3:82725260-82725261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576274198 | chr3:82725323-82725324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376735442 | chr3:82725386-82725387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149790000 | chr3:82725401-82725402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147936763 | chr3:82725444-82725445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11925824 | chr3:82725451-82725452 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs182759296 | chr3:82725468-82725469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs80159050 | chr3:82725525-82725526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113723838 | chr3:82725667-82725668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187310362 | chr3:82725673-82725674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193201967 | chr3:82725678-82725679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562765786 | chr3:82725747-82725748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531815558 | chr3:82725753-82725754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7626250 | chr3:82725784-82725785 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs547713840 | chr3:82725819-82725820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373432640 | chr3:82725874-82725875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185524420 | chr3:82725876-82725877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375305798 | chr3:82725888-82725889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547777356 | chr3:82725912-82725913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567517619 | chr3:82725917-82725918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536763132 | chr3:82725949-82725950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78216797 | chr3:82725956-82725957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113337143 | chr3:82725964-82725965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs386662955 | chr3:82726010-82726011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71616426 | chr3:82726011-82726012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372026582 | chr3:82726012-82726013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113104238 | chr3:82726023-82726024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71112044 | chr3:82726028-82726029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs58164008 | chr3:82726030-82726031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs202106009 | chr3:82726031-82726032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200208222 | chr3:82726034-82726035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375174228 | chr3:82726043-82726044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189094054 | chr3:82726074-82726075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs75137157 | chr3:82726091-82726092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558471571 | chr3:82726135-82726136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572310146 | chr3:82726160-82726161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:82720600-82721000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr3:82725200-82726200 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr3:82725800-82726400 | Enhancers | HMEC | breast |
4 | chr3:82727200-82727800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr3:82727600-82728000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr3:82727800-82731400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr3:82731400-82731600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr3:82731600-82737200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr3:82734600-82735800 | Enhancers | NH-A | brain |
10 | chr3:82737200-82737600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr3:82737200-82737600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr3:82756200-82756800 | Enhancers | Dnd41 | blood |
13 | chr3:82758200-82758800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
14 | chr3:82758200-82759000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |